Business Context and Reporting Period
This Form 8-K Current Report was filed by TherapeuticsMD, Inc. on December 17, 2021, covering the event date of December 13, 2021. The company is a Nevada corporation with its principal executive office in Boca Raton, Florida, and its common stock trades on The Nasdaq Stock Market LLC under the symbol TXMD.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The primary material change reported is the resignation of a director:
- Departure: Mr. J. Martin Carroll notified the Company of his decision to resign from the Board of Directors.
- Effective Date: The resignation is effective December 31, 2021.
- Reason: The resignation is not due to any disagreement between the Company and Mr. Carroll regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Investor Verification Checklist
- Verify the effective date of Mr. Carroll's resignation (December 31, 2021).
- Confirm whether a replacement director has been nominated or elected to fill the vacancy.
- Review subsequent filings for any impact on board composition or committee assignments.